RARA and acute promyelocytic leukemia: RARα plays a role in granulocytic differentiation of hematopoietic cells and the abnormal chimeric receptor PML-RARα has been implicated in APL pathogenesis by blocking the myeloid differentiation program and enhancing self-renewal of leukemic cells [3], [4].